VESTAL, N.Y. — The Binghamton University School of Pharmacy and Pharmaceutical Sciences has signed an articulation agreement with Ithaca College.
The pact will allow students to transfer into Binghamton’s doctor of pharmacy (PharmD) program after three years of undergraduate study, Binghamton announced.
It is a 3+4 program that will allow qualified Ithaca College students to complete their bachelor’s degree through coursework taken in their first professional year at Binghamton.
(Sponsored)
Why Now Is the Time To Start Planning for Your Company’s Business Succession
You’ve built a great business, and you love what you do. Retirement is a long way off, so why worry about how you’ll transition the ownership of your company down
Cybersecurity in Today’s Remote Work Environment
The response to the COVID-19 pandemic demonstrated that remote work was viable for many companies. Today, remote and hybrid work models have become standard options for most professionals. While remote
“This agreement solidifies the mutual commitment Binghamton University has with Ithaca College to support the preparation of outstanding pharmacy professionals who will focus on patient-centered care,” Gloria Meredith, founding dean of the School of Pharmacy and Pharmaceutical Sciences, said in a statement. “As we expand our reach throughout New York state, it is gratifying to have developed these strong connections and we look forward to enrolling highly qualified students from Ithaca College.”
Students must have successfully completed the prerequisite credits from Ithaca College and apply no later than Jan. 1 of the year they plan to enroll at Binghamton. They must also carry a minimum cumulative and math/science grade point average of 3.0.
The school will waive the Pharmacy College Admissions Test (PCAT) for students who meet those qualifications.
Candidates in good standing will have the option of spending their fourth year at Ithaca College to complete their bachelor’s degree, rather than at Binghamton University in the first year of the PharmD program. This option will necessarily extend the length of the program to eight years, rather than the seven years of the 3+4 program, Binghamton said.
“We believe this program will benefit both campuses by attracting academically promising students, ultimately yielding well-prepared professionals for the field,” Linda Petrosino, dean of IC’s School of Health Sciences and Human Performance, said.
Binghamton’s School of Pharmacy also has 3+4 agreements with Cornell University College of Agriculture and Life Sciences and Wells College, along with 2+4 programs with SUNY Broome Community College, Onondaga Community College, and SUNY Nassau Community College, per the news release.
Contact Reinhardt at ereinhardt@cnybj.com
